…umab) are often used in ovarian and cervical cancers. ICIs (eg, pembrolizumab) are effective in mismatch repair-deficient endometrial cancer …
Imatinib
This drug is selected. Its supporting articles are shown below.
Articles mentioning Imatinib
8 articles · page 1 of 1…matinib had 22.86% of the adherence odds compared with those on nilotinib. The findings suggest that maintaining high medication adherenc…
…9 life years; 95% CI 7929 to 8220; 10.8%; figure 4). The use of nivolumab to treat melanoma, pembrolizumab to treat non-small cell lung c…
… 5% had ovarian, renal or lung cancer. The involved drugs were: enzalutamide(25), apalutamide(14), abiraterone (9), abemaciclib(6), capecita…
…t was stabilised with hydroxyurea and subsequently commenced on imatinib, achieving haematological remission, while supportive measures …
… location, size and mitotic index. In high-risk cases, adjuvant imatinib therapy is warranted.…
…rget effects and mechanistic insights.Results Perturbation with tripolide, doxorubicin, and cobimetinib resulted in dose dependent cell t…
…6V genetic mutation resistant to Imatinib. She was treated with Fexofenadine, emergency adrenaline Epipen and intermittent prednisolone. Rep…